Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. (AMRX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AMRX · as of Sep 30, 2024
Ownership Breakdown
186
Institutional Holders
▲ 2 vs Q2
$1.19B
Total Inst. Value
▲ $307.23M vs Q2
319.02M
Shares Outstanding
freeFloat 49.00%
142.73M
13F Shares Held
▲ 4.09M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AMRX largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
UBS GROUP AG pharmaceutical preparations | 21.77M | 7.03% | 7.03% | $181.15B | Nov 14, 2024 | ▼ 76.5K |
VANGUARD GROUP INC pharmaceutical preparations | 14.62M | 4.72% | 4.72% | $121.67B | Nov 13, 2024 | ▲ 629.8K |
BLACKROCK, INC. pharmaceutical preparations | 12.41M | 4.01% | 4.01% | $103.26B | Nov 13, 2024 | NEW |
TPG GP A, LLC pharmaceutical preparations | 12.33M | 3.98% | 3.98% | $102.58B | Nov 14, 2024 | — held |
RUBRIC CAPITAL MANAGEMENT LP pharmaceutical preparations | 10.72M | 3.46% | 3.46% | $89.21B | Nov 13, 2024 | — held |
CITADEL ADVISORS LLC pharmaceutical preparations | 8.89M | 2.87% | 2.87% | $73.98B | Nov 14, 2024 | ▼ 1.10M |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 4.71M | 1.52% | 1.52% | $39.21B | Nov 7, 2024 | ▲ 429.1K |
NEUBERGER BERMAN GROUP LLC pharmaceutical preparations | 3.79M | 1.22% | 1.22% | $31.49B | Nov 14, 2024 | ▲ 219.3K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 3.79M | 1.22% | 1.22% | $31.51B | Nov 12, 2024 | ▲ 378.1K |
STATE STREET CORP pharmaceutical preparations | 3.51M | 1.14% | 1.14% | $29.24B | Nov 14, 2024 | ▲ 127.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
30
Increased
+11.47M shares1
New Positions
first time holders14
Decreased
−5.16M shares0
Sold Out
fully exitedNet shares change (top 50)
+6.32M
+11.47M / −5.16M
Net new holders
+17
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AMRX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
16
Buy transactions
9
Sell transactions
1.78
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Autor Deborah M. director | May 11, 2026 | Sale | 34,819 | $12.94 | $450.6K | 93.7K | Form 4 ↗ |
BUCHI J KEVIN director | May 6, 2026 | Award | 19,824 | — | — | 19.8K | Form 4 ↗ |
Autor Deborah M. director | May 6, 2026 | Award | 19,824 | — | — | 19.8K | Form 4 ↗ |
George Jeffrey P. director | May 6, 2026 | Award | 19,824 | — | — | 19.8K | Form 4 ↗ |
Patel Gautam director | May 6, 2026 | Award | 19,824 | — | — | 19.8K | Form 4 ↗ |
Kiely John director | May 6, 2026 | Award | 19,824 | — | — | 19.8K | Form 4 ↗ |
Nark Ted C director | May 6, 2026 | Award | 19,824 | — | — | 19.8K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Amneal Pharmaceuticals, Inc. (AMRX) is primarily owned by institutional investors, who hold approximately 44.7% of total shares outstanding. Company insiders own approximately 51.00%, while retail and public investors account for the remaining 4.26%.
The largest institutional shareholder of Amneal Pharmaceuticals, Inc. is UBS GROUP AG, holding approximately 21.77 million shares — equal to 7.03% of outstanding shares — as of September 30, 2024.
A total of 186 institutional investors currently hold AMRX stock, with a combined institutional value of approximately $1.19 billion as of the most recent 13F filing period.
Frequently asked questions
AMRX ownershipAmneal Pharmaceuticals, Inc. (AMRX) is primarily owned by institutional investors, who hold approximately 44.7% of shares. The largest shareholder is UBS GROUP AG with a 7.03% stake. Company insiders hold 51.00%. Data sourced from SEC Form 13F as of September 30, 2024.